NCT00264888View on ClinicalTrials.gov

Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy

PHASE2CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG

PTC124

Trial Locations (3)

84112

University of Utah, Salt Lake City

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

19104-4399

Children's Hospital of Philadelphia, Philadelphia

Sponsors

Lead Sponsor

PTC Therapeutics

All Listed Sponsors

collaborator

Muscular Dystrophy Association

OTHER

lead

PTC Therapeutics

INDUSTRY

NCT00264888 - Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy | Biotech Hunter | Biotech Hunter